Application 217559
- Type
- ANDA
- Sponsor
- REGCON HOLDINGS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | THIOTEPA | THIOTEPA | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | 15MG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217559-001 | THIOTEPA | THIOTEPA | 15MG/VIAL | POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | AP | 2024-08-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A217559-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A217559-001 | THIOTEPA | 15MG/VIAL | POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | AP | 2024-08-20 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217559-001 | THIOTEPA | 15MG/VIAL | POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | AP | 2024-08-20 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A217559-001 | THIOTEPA | 15MG/VIAL | POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | AP | 2024-08-20 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217559-001 | THIOTEPA | 15MG/VIAL | POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | AP | 2024-08-20 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217559-001 | THIOTEPA | 15MG/VIAL | POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | AP | 2024-08-20 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217559-001 | THIOTEPA | 15MG/VIAL | POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | AP | 2024-08-20 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217559-001 | THIOTEPA | 15MG/VIAL | POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | AP | 2024-08-20 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A217559-001 | THIOTEPA | 15MG/VIAL | POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | AP | 2024-08-20 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A217559-001 | THIOTEPA | 15MG/VIAL | POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | AP | 2024-08-20 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A217559-001 | THIOTEPA | 15MG/VIAL | POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | AP | 2024-08-20 | d06236e962d9… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217559-001 | THIOTEPA | 15MG/VIAL | POWDER / INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | AP | 2024-08-20 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A217559-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217559-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A217559-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217559-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217559-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217559-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217559-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A217559-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A217559-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A217559-001 | AP | 1 | d06236e962d9… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217559-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TEPADINA | THIOTEPA | Amneal Pharmaceuticals LLC | 559e353c-2dc0-16ba-e054-00144ff8d46c | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | THIOTEPA |
| Thiotepa | THIOTEPA | Gland Pharma Limited | 6cd6ae89-c553-4328-9262-4363610a1f19 | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | Thiotepa THIOTEPA |
| Thiotepa | THIOTEPA | Sagent Pharmaceuticals | 448c29f1-6d9c-4f8e-8a69-9b85e973e728 | 2025-10-20 | Warnings, Adverse reactions | Thiotepa THIOTEPA |
| TEPYLUTE | THIOTEPA | Shorla Oncology Inc. | add44e98-a042-4e38-b870-beb36693805b | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | THIOTEPA |
| Thiotepa | THIOTEPA | Novadoz Pharmaceuticals LLC | b702dcc9-dd0e-4386-b1e2-f20562fd2ad9 | 2024-04-14 | Boxed warning, Warnings, Adverse reactions | Thiotepa THIOTEPA |
| Thiotepa | THIOTEPA | Meitheal Pharmaceuticals Inc | 4b4725eb-95f1-45cc-852f-152beb5f1e2c | 2023-12-27 | Boxed warning, Warnings, Adverse reactions | Thiotepa THIOTEPA |
| Thiotepa | THIOTEPA | Hikma Pharmaceuticals USA Inc. | 9ae8063c-ba28-4da2-a94c-8e1a5f75e4b3 | 2023-05-31 | Boxed warning, Warnings, Adverse reactions | Thiotepa THIOTEPA |
| Thiotepa | THIOTEPA | Hikma Pharmaceuticals USA Inc. | 6dc898dc-5949-4aa4-83f8-4bd20c29eb93 | 2023-05-24 | Warnings, Adverse reactions | Thiotepa THIOTEPA |
| Thiotepa | THIOTEPA | Dr.Reddy's Laboratories Inc., | a8c8bb14-0423-e4a3-8bf0-8a66ce05b1bb | 2022-11-01 | Boxed warning, Warnings, Adverse reactions | Thiotepa THIOTEPA |
| Thiotepa | THIOTEPA | Fresenius Kabi USA, LLC | 493410f3-0733-4f76-8050-6529d96f2a5b | 2022-03-28 | Boxed warning, Warnings, Adverse reactions | Thiotepa THIOTEPA |
| Thiotepa | THIOTEPA | Hikma Pharmaceuticals USA Inc. | b19b03db-471d-4ee7-b1b8-6eccc39c41b0 | 2021-04-02 | Warnings, Adverse reactions | Thiotepa THIOTEPA |
| Thiotepa | THIOTEPA | Dr.Reddy's Laboratories Inc., | 0def6a5e-4bf5-b1fd-47b7-0f17ecfd9bc2 | 2018-04-25 | Warnings, Adverse reactions | Thiotepa THIOTEPA |